What is the Impact Factor of Therapeutic Innovation & Regulatory Science?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Therapeutic Innovation & Regulatory Science is 2.10, ranking in quartile Q4 of Web of Science (SCIE).

Is Therapeutic Innovation & Regulatory Science indexed in Web of Science or Scopus?

Yes, Therapeutic Innovation & Regulatory Science is indexed in Web of Science (SCIE, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.902 (Q1) and an H-index of 57.

Who publishes Therapeutic Innovation & Regulatory Science and what is the Article Processing Charge (APC)?

Therapeutic Innovation & Regulatory Science is published by Springer International Publishing. The estimated Article Processing Charge (APC) is approximately $3,057 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Therapeutic Innovation & Regulatory Science?

The official ISO-4 abbreviation of Therapeutic Innovation & Regulatory Science is "THER INNOV REGUL SCI" with common acronym "tirs". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q4Scopus Q1SCImago #5,768Hybrid

Therapeutic Innovation & Regulatory Science

Acronym:tirs

•

Abbreviation (ISO):THER INNOV REGUL SCI

•

Identifier (ISSN):2168-4790(Print)/2168-4804(Online)

•

Publisher:Springer International Publishing

Official Website Submission Portal Compare

Clarivate IF (2026)

2.1↑ +0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Therapeutic Innovation & Regulatory Science

WoS Q4

Annual Impact Factor Metric

Current (2026):2.1

Scopus SJR & RankScopus Q1

0.902

#5,768

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

57 papers with at least that number of citations each

WoS: SCIE / JCRQ4

Self-Citation Rate10%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

102articles/year

46.65% Gold OA•77.87% Original Research

Aims & Scope

Therapeutic Innovation & Regulatory Science (TIRS) is the official scientific journal of DIA that strives to advance medical product discovery, development, regulation, and use through the publication of peer-reviewed original and review articles, commentaries, and letters to the editor across the spectrum of converting biomedical science into practical solutions to advance human health. The focus areas of the journal are as follows: Biostatistics Clinical Trials Product Development and Innovation Global Perspectives Policy Regulatory Science Product Safety Special Populations

Topics Covered (Recognized by AI)

Medicine96.5%Political science80.8%Law80.5%Biology77.6%Nursing70.4%Family medicine70.1%Pharmacy68.2%Economics55.2%Business54.5%Computer science52.1%Internal medicine51.8%Pathology50.7%Psychology44.9%Mathematics44.1%Pharmacology42.5%Bioinformatics36.1%Statistics35.2%Physics33.6%Psychiatry30.8%Clinical trial30.3%Engineering29.2%Philosophy27.2%Management26.6%Drug25.5%Risk analysis (engineering)21.8%Sociology21.6%

Primary Research Areas

Medical Informatics Pharmacology & Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

MEDICAL INFORMATICS

Rank46/54

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank240/356

IndexSCIE

JCISCIE2026

MEDICAL INFORMATICS

Rank48/55

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank252/356

IndexSCIE

Category	Index	Rank	Quartile
MEDICAL INFORMATICS	JCRSCIE	46/54	Q4
PHARMACOLOGY & PHARMACY	JCRSCIE	240/356	Q3
MEDICAL INFORMATICS	JCISCIE	48/55	Q4
PHARMACOLOGY & PHARMACY	JCISCIE	252/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.1

Articles / Year144

Total Citations25

2025

IF1.9

Articles / Year168

Total Citations338

2024

IF2

Articles / Year132

Total Citations548

2023

IF1.5

Articles / Year111

Total Citations868

2022

IF1.337

Articles / Year134

Total Citations1,543

Year	Impact Factor	Articles / Year	Total Citations
2026	2.1	144	25
2025	1.9	168	338
2024	2	132	548
2023	1.5	111	868
2022	1.337	134	1,543
2021	1.778	109	1,441
2020	0.92	223	2,333
2019	0.901	122	958
2018	0.882	147	1,700
2017	—	129	1,783
2016	—	98	1,573
2015	—	110	1,410

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,768Scopus Q1SCImago Profile

Scopus Coverage:1970, 1972, 1974-2006, 2008-2011, 2013-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

0.902

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

2.70

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,057 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations967

3-Year Documents345

Citable Documents318

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)5

Citations in government and international policy documents

Female Author Rate51.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1

Public Health, Environmental and Occupational HealthQ1

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 10%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区MEDICAL INFORMATICS

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Therapeutic Innovation & Regulatory Science (acronym: tirs, abbr: THER INNOV REGUL SCI, ISSN: 2168-4790) is a peer-reviewed international scholarly journal in the field of MEDICAL INFORMATICS, published by Springer International Publishing in United States since 1997. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.902 (Q1), an H-index of 57.

The journal enforces rigorous peer evaluation with a publication frequency of 6 issues per year, an annual output of approximately 102 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,057 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.